Experiment 69408
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Panax ginseng (ARALIACEAE) |
| Citation | ELLIS,JM: REDDY,P:. (2002). EFFECTS OF PANAX GINSENG ON QUALITY OF LIFE.. 36() |
| Amount utilized | |
| Compound isolated | |
| Disease | USE. MORE LIKELY TO STATE THAT THEY RECEIVED ACTIVE THERAPY THAN SUBJECTS GIVEN PLACEBO (17%; P<0.05). P.GINSENG IMPROVES ASPECTS OF MENTAL HEALTH AND SOCIAL FUNCTIONING AFTER 4 WEEKS OF THERAPY, ALTHOUGH THESE DIFFERENCES ATTENUATE WITH CONTINUED PATIENTS RANDOMIZED TO P.GINSENG; THESE DIFFERENCES DID NOT PERSIST TO THE 8-WEEK TIME POINT. THE INCIDENCE OF ADVERSE EFFECTS WAS 33% IN THE P.GINSENG GROUP COMPARED WITH 17% IN THE PLACEBO GROUP (P=0.40). SUBJECTS GIVEN P. GINSENG (58%) WERE (P.GINSENG 54.9 + 4.6 VS. PLACEBO 49.2 + 6.5; P=0.014), MENTAL HEALTH (P.GINSENG 52.2 + 7.7 VS. PLACEBO 47.2 + 7.3; P= 0.075), AND THE MENTAL COMPONENT SUMMARY (P.GINSENG 51.3 + 7.4 VS. PLACEBO 44.3 + 8.3; P=0.019) SCALES WERE OBSERVED IN ANALYSIS OF COVARAIANCE. A P VALUE <0.05 WAS CONSIDERED STATISTICALY SIGNIFICANT. THERE WERE NO SIGNIFICANT DIFFERENCES IN BASELINE DEMOGRAPHICS AND SF-36V2 SCORES BETWEEN THE GROUPS. AFTER 4 WEEKS OF THERAPY, HIGHER SCORES IN SOCIAL FUNCTIONING 8 WEEKS. THE SHORT FORM-36 HEALTH SURVEY VERSION 2 (SF-36V2), A VALIDATED GENERAL HEALTH STATUS QUESTIONNAIRE, WAS USED TO ASSESS HRQOL AT BASELINE AND AT 4 AND 8 WEEKS. HRQOL BETWEEN THE GROUPS WAS COMPARED BY USE OF REPEATED-MEASURES TO ASSESS THE TIME-DEPENDENT EFFECTS OF PANAX GINSENG ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) BY USE OF GENERAL HEALTH STATUS QUESTIONNAIRE. SUBJECTS WERE RANDOMIZED IN A DOUBLE-BLIND MANNER TO P.GINSENG 200 MG/D (N=15) OR PLACEBO (N=15) FOR |
| Dose amount | 200.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | HYDRO-ALCOHOLIC EXT |
| Gender | GIVEN TO BOTH SEXES |